Mineralocorticoid receptor antagonists reduce risk of cardiovascular events in patients with heart failure Post author: Post published:September 3, 2024 Post category:uncategorized MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients. You Might Also Like Two genetic variants linked to Alzheimer’s trigger microglial inflammation in females September 30, 2024 Ultra-rare gene variants drive coronary artery disease risk in European ancestry October 13, 2024 Early exposure to air pollution associated with lower economic earnings in adulthood September 9, 2024
Two genetic variants linked to Alzheimer’s trigger microglial inflammation in females September 30, 2024
Early exposure to air pollution associated with lower economic earnings in adulthood September 9, 2024